Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rubicon Launches Simplest, Fastest, Most Sensitive Sample Prep for NGS

Published: Thursday, May 17, 2012
Last Updated: Thursday, May 17, 2012
Bookmark and Share
First product ThruPLEX-FD for fragmented DNA delivers highly sensitive and consistent results from range of sample types in just 2 hours.

Rubicon Genomics, Inc. has announced the launch of the first product in its innovative ThruPLEX™ family of sample preparation kits designed and optimized for next generation sequencing (NGS).

ThruPLEX-FD kits leverage Rubicon’s patented DNA repair and ligation methods to deliver significantly faster and more sensitive sequencing of plasma, formalin-fixed, ChIP and other fragmented DNA with substantially increased throughput.

ThruPLEX kits are also applicable to sample preparation for PCR and microarray testing.

“The accelerated adoption of NGS technology has created a demand for faster and more sensitive sample preparation,” noted James Koziarz, CEO of Rubicon.

Koziarz continued, “Breaking with the traditional multi-step process requiring intermediate transfers and purifications, ThruPLEX uses more efficient enzymology to repair, ligate and amplify the DNA molecules in a single tube. Our patented three-step process enables high quality sequencing of clinical samples that were previously too small or degraded to be tested.”

Henry Long, Ph.D., Associate Director of the Center for Functional Cancer Epigenetics at the Dana-Farber Cancer Institute, commented, “Our experience with the ThruPLEX-FD library prep has been extremely positive. Both at Rubicon and in our hands it has proven able to generate high quality, diverse libraries from 10-times less input than other kits we have used. For us this technology truly enables the study of samples that simply weren’t possible before adopting it.”

ThruPLEX-FD is a streamlined one-tube, three-step process without intermediate purifications, transfers, columns or gels. The reduced steps and material transfers decrease the likelihood of experimental variability, bias and contamination.

DNA is sequencing-ready in two hours with as little as 15 minutes of hands-on time. A technician can prepare 192 ThruPLEX samples a day-a 15-fold increase in productivity compared to current methods.

ThruPLEX-FD is designed and validated for use with samples as small as 50 picograms of human DNA and can be used in plasma, FFPE, cDNA, ChIP and population studies.

ThruPLEX-FD is currently available as 48-reaction, 12-index kits for sequencing on Illumina® HiSeq®, MiSeq® and Genome Analyzer instruments. ThruPLEX-FD kits are also being developed for additional formats and platforms.

Mr. Koziarz continued, “ThruPLEX-FD highlights the power of this new technology, producing accurate and reproducible results from very small amounts of fragmented DNA. We believe our ThruPLEX products will facilitate wider use of NGS and look forward to releasing additional ThruPLEX products later this year.”

For more information about ThruPLEX-FD, visit www.rubicongenomics.com/products/ThruPLEX-FD.

Separately, Rubicon has announced that Kenneth Solomon has joined the company as Director, Sales and Marketing.

Mr. Solomon has extensive experience in marketing, sales and sales management for technologically advanced biomedical products, holding positions of increasing responsibility at Centocor Ortho Biotech, Pharmacia/Searle, Biomet, Boehringer Mannheim and others.

Mr. Koziarz commented,” Ken is a seasoned sales professional who brings us a track record of success in building market and product awareness for innovative biomedical products in both large and start-up companies. He has managed sales organizations addressing a variety of biomedical customers, including academic and research centers. As we further expand our product line of advanced pre-analytical amplification technologies, Ken will be instrumental in establishing Rubicon as a premier company in this rapidly growing sector.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rubicon Partners with Diagenode for ChIP Sample Preparation
Combining Rubicon ThruPLEX™ and Diagenode technologies enables scientists to efficiently conduct high quality ChIP studies from small samples for NGS and array analysis.
Monday, November 05, 2012
Rubicon Genomics’ PicoPlex™ Technology Enables International Clinical Genetic Study of Single Human Cells
PicoPlex technology validated for accurate testing of single human cells to diagnose genetic abnormalities in advance of assisted reproduction.
Thursday, July 01, 2010
bicon Genomics, Inc. Creates Scientific Advisory Board

Friday, May 31, 2002
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Device May Detect Urinary Tract Infections Faster
A Lab-on-a-Disc platform developed by a German and Irish team of researchers dramatically cut the time to detect bacterial species that cause urinary tract infections -- a major cause of sepsis.
Automation Abound at AACC in Atlanta
Discover the latest breakthroughs, trends and products from the AACC Annual Meeting & Clinical Lab Expo.
Real-Time Data for Cancer Therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!